PRISCA™ Software Overview Video

Friska prenatal risk calculation. Software overview. Video Priscus software calculates the risk of chromosomal abnormalities in the 1st and 2nd trimesters of pregnancy. The risk calculation is based on the mother's age, the gestational age of the fetus, biochemical test results, ultrasound measurements. An correction factors such as maternal weight. Prisca provides numerous test protocols, gestation elhage calculation methods, and a choice of reporting formats. There are three main patient tabs with in the software list, patient and details and the right side toolbar is iaccessible. Within each tab, the list tab. The list tab shows the list of patients in the database and allows the user to sort and search according to the column headers. The color coding indicates the number of reports, if any, that the user has printed reports of multiple patients can be batch printed from this tab, the patient tab. We will start the navigation by adding a new patient. Select the new button on the right to create a blank record. Enter the mothers last and first names. It is highly recommended to also enter both patient and sample ID's along with the physician's name to more easily identify the patient. After the mother's date of birth is entered, Presco will calculate the age and age risk. Several fields have an impact on the risk. These fields include maternal weight in kilograms, whether the mother is a smoker or has diabetes. The ethnicity of the mother and whether it is an in vitro fertilized or twin pregnancy. This example will demonstrate the result of data entered for a first trimester pregnancy. The risk will be based on biochemical test results and ultrasound measurements. Select the scenographer from the dropdown list. The CRL or Crown rump length along with the date the measurement was taken are entered. Next, the date of sampling is entered. Prisca then calculates the gestational age of the fetus in weeks and days as of the ultrasound date and sample date. The blue fields indicate the data that Prisca has calculated and cannot be directly modified, the nuchal translucency measurement is entered next. Kriska then calculates the nuchal translucency. Mom or multiple of the medium. Now we will enter the biochemical test results. Priske will calculate medians for the first 2 markers free beta H CG. Based on the gestation elhage at the date of sampling. After entering the values for these two test results are omom is calculated priske then calculates a corrected mom. This is a correction of the raw mom based on the correction factors previously entered calculated risks on the panel on the right appear. The risks are expressed as ratios. The first 2 biochemistry risks or calculations for trisomy 21 or Down syndrome. The second ratio is a combined risk ratio, which means it includes the nuchal translucency. The risks displayed in this example are very low. The risk for Trisomy 13 and 18 is also calculated. The NTD or neural tube disorder risk is not calculated since it depends on 2nd trimester markers. 2nd trimester quadruple screening. In this example, we will enter in the same information previously required, including the date of sampling the gestation age on the date of the sampling is entered directly and not calculated by priska. There will be no ultrasound information because the value entered in the gestation elhage on the date of sampling field is in the 2nd trimester. The medians for these biochemical values will automatically be entered or calculated. These markers include free beta H CG. Or Alpha Feto protein total HCGU E3, or unconjugated. Estriol and inhibin a once the patients results are entered. We see that this is another low risk patient based on the trisomy 21 biochemistry risk, and the risk for trisomy 18. Selecting the report button will display the patient's report. There are several report formats for each protocol type, which can be configured in the settings. Some report formats include a graph to clearly display the mothers risk. Specific report formats can be assigned to a particular doctor based on their preference, the details tab. The Details tab allows the user to record additional risk factors for the patient, including previous trisomy 21 pregnancies and absence of nasal bone. This information can have a significant impact on the risk and should be entered if available. There are two fields for comments. The first can optionally appear on the patient report, depending on the format selected. The other is for additional user notes and does not appear on printed reports. On this tab. You can also record data about the progress and outcome of the pregnancy. For more information about the Priske software visit PE Connect.

Report Special Information Help Record Service Record Service Special Information Record Service Special Special Information Special Information Help ? Help List Patient Details Details List List Patient risk Patient Details Patient data Patient Katient Patient ID Patient D CGlose Close MothersLast2 No repon printed No repotl printed printed Last n Mothers MothersL_ast Mothersl_yst MothersFirst Mothersfirst? MothersL_yrst2 MothersFirst? Mothersl_ast? Mothersl_ast2 Mothersl_yst? MothersL_yst2 Mothersl_yst2 Sonograph DC? 1 Snnoqraph LIC8 Sonograph CIC8 Snnoqraph DC3 Sonograph ÜC3 MothersFirst2 MothersLast2 Last name Las' name First name Sonograph Snnoqraph Search tot Beatch Name: Risk calculation One report printed Neural tube defects risk at sampling date Date 01 sampling at sampling Oate of sampling at clate at term Patient OD Patient Patient ID Patient Deta Patient data MothersLarst2 First n Lawison Mothersl_ast MothersFirst2 M thersFirs Mothersl_ast2 MothersFirst Mothersl_yst MothersL_arst MothersFlrast Number ot ftetuses Patient data Last name First nama First name i'.iumber Cit fetuses ['dumber Cit fetuses Number ot tetuses i'.iumber ietuses Number otie Number Number at fetuses Number ot fetuses Number fetuses Number Qt fetuses Number tetuses New More than one report printed More thdn one report printed Last name In column In colum Historical Report Age risk NTD risk risk ethnic origin Patient OD Data Patient IQ Patient Patient ID Patient data Patient D patient data Dalete Delete Dialetes - Delete Dcarlete Age risk„ Previous trisomy 21 pregnanoes Comment Gestation age (date of scann + Gestation age (date of scann Previous tnsorny 21 pregnancies Sample iÜ Sample Date Sample iCj Sample ID Sarnp\e ID Gestation age (date oi scan) Gestation age (date scan) Gestation (date scan) Gestation Gestation (date oi scan) Gestation age (dale oi scan) Gestation age on the date ot sampling Gestation age on the date oi sampling Caucasian Biochemisty risk Biochem risk Biochemistry Biochemistry risk. Biochermr risk NT Biocheristry risk Biocherm risk NT Biochemistry risk Biocherm risk Biochemrv risk NT Biocherr.istry risk Biocherm risk + NT aiochemistry Biochemr.istry risk BiocheryL risk N T Date Sample present Nasal bone Dalete Save Delete Savple Kate - Delete Jade physician Physician Date 01 sampling Date ot sampling Date 01 samplinrg Date sampling Date of sampling Date sam iin Sample Date Patient ID Patient OD Last name Las' name First name Date birth Date ot birth Exclude this patient from median Exclude this patient from med.an calculati Gestation age on the date of sampling Gestation age on the date oi sampling Gestat'on age on the date sampling Gestation age an the date sampling Gestation age on the date ot sampling Gestation age sampling Gestation age on the date o sampling Sort Seport Dale oi birr Dale birr 1 Dale of birr 10/10/ Dale birr 1 0/88 Date birt Dale oi birr _ 7/_2/8E Date ot birt Date birt 10/10/88 Date bin I Date birth Date bin 1 g/ 8B Date bin I g/ 8B Date bin 1 2/1 g/ 83 Dale birr Date bin 1 / g/ 8B Date bin I / g/ 8B that 21 Amniocentesis CVS erminatlon pregnan determination methad Termination pregnan Weight Find Biochemrv risk NT Biochem risk NT Biochem risk Biocherm risk NT Effochærrv r;sk NT Effochem risk Effochæm risk Biocherm risk Biocherm risk + NT Biochenrm risk + NT Biochern risk Biochemistry r'sk BiochernL risk + NT BiocherrL risk + NT risk 18 determination methad determination method _ pApp _ NT _ pApp _ W T unknown Scarlette Scarletl Smoking No amniocentesis Report Result NC. amniocentesis COS Nuchal translucency translucency 15 Patient Details unknown uInknown whith diabetes information. Value Intrauterine de Report No karyotype Karyoypa / Diagnosi 01 MOM Seport Result NC. karyotypæ Karyotype / Diagnosls ethnic o Asdian Median Caucasit Caucasi Caucasic Caucasic • Astan patient data ethnic origin Age risk: unknown Corrected Meorgana Georgia Gentgla Other unknown uInknown iVF pregnency B/F pregnancy 'VF pregnancy iVF pregnancy 'VF pregnency IVF pregnancy a etch Batch Beatch aatch 11 15 Markers Value Mediaon Median Asdian Median MO Corrected MOM Corrected Birth wirth 17 Lara Free 13 Il a I-C a hC No karyotype Dalete Save Datient Diagnosis NTD risk risk Alisha pApp_A I 13 pApp_A PA pp_A Week of pregnan 'VF pregnancy 'vVeek pregnan SCREENING Unknown Risk trisorm/ 13/18 Risk tor trisornv 13/18 Risk tor trisorm/ 1 3/18 Risk trisc.rnv 13/18 Risk tor tnisorm/ 13/18 Risk tor trisomv 1 3/18 Risk risk 13 These comments do not appear on reports. Comment HCG HDG which a risk. Georgina with Value Patient data Risks at term Charlotte unknown Ethnic origin Neural tube defects risk Re-calculate Inhibi Median Morgan Age risk: Inhibin-A Inhihin-A inhihin-A 14 Caucasian 237212372 el Age risk that PatÉnt O Metcalfe ? Help Help Ethnic o Caucasian 13 SCREENING Metcalfe 21 l_JAge risk Close VVatts Watts Louise Louiae Last alterations by: superuser Sophia